ANASTASIS BIOTEC LIMITED

10502511
Active London

Research and experimental development on biotechnology

3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

ANASTASIS BIOTEC LIMITED

10502511

Research and experimental development on biotechnology

Founded 29 Nov 2016 Active London, United Kingdom 3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 19 Nov 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 7 Nov 2025 Next due 21 Nov 2026 5 months remaining
Net assets £84K £31K 2024 year on year
Total assets £167K £34K 2024 year on year
Total Liabilities £83K £3K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

56 Haverstock Hill Haverstock Hill London NW3 2BH United Kingdom

Website

www.example.com

Full company profile for ANASTASIS BIOTEC LIMITED (10502511), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 29 Nov 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2017–2024)

Cash in Bank

£78.33k

Decreased by £42.99k (-35%)

Net Assets

£84.31k

Decreased by £31.17k (-27%)

Total Liabilities

£83.11k

Decreased by £3.00k (-3%)

Turnover

N/A

Employees

3

Debt Ratio

50%

Increased by 7 (+16%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 2

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

113 Allotments 690,090 Shares £16936.99m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Sept 2025169,680£75k£0.442
1 Sept 2025169,680£75k£0.442
3 Jun 202540£280£7
3 Jun 202530£210£7
3 Jun 2025286£2k£7

Officers

Officers

1 active 2 resigned
Status
Christina Andrea KousparouDirectorCypriotCyprus516 Feb 2024Active

Shareholders

Shareholders (97)

Agamemnon Epenetos
65.9%
2,316,670
Laurence Cohen
15.6%
547,400

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Agamemnon Antoniou Epenetos

British

Active
Notified 29 Nov 2016
Residence United Kingdom
DOB October 1949
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 May 2026MiscellaneousReplacement filing of SH01 - 20/04/26 Statement of Capital gbp 35507.30
1 May 2026ResolutionResolutions
1 May 2026ResolutionResolutions
31 Dec 2025CapitalAllotment of shares (GBP 35,173.94) on 29 Oct 2025
19 Nov 2025AccountsAnnual accounts made up to 31 Dec 2024
12 May 2026 Miscellaneous

Replacement filing of SH01 - 20/04/26 Statement of Capital gbp 35507.30

1 May 2026 Resolution

Resolutions

1 May 2026 Resolution

Resolutions

31 Dec 2025 Capital

Allotment of shares (GBP 35,173.94) on 29 Oct 2025

19 Nov 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Replacement filing of SH01 - 20/04/26 Statement of Capital gbp 35507.30

1 months ago on 12 May 2026

Resolutions

1 months ago on 1 May 2026

Resolutions

1 months ago on 1 May 2026

Allotment of shares (GBP 35,173.94) on 29 Oct 2025

5 months ago on 31 Dec 2025

Annual accounts made up to 31 Dec 2024

7 months ago on 19 Nov 2025